Physician profile
John S Taylor
NPI 1740228055
$702.42
in general payments reported to CMS, 2019-2025
18 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $64.09 · 2021: $60.03 · 2023: $46.32 · 2024: $13.91 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.10 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $141.11 | 2021-2025 | |
| Glaxosmithkline, LLC. | $135.14 | 2019-2023 | Bexsero |
| Novo Nordisk INC | $85.50 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Allergan, INC. | $58.67 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $53.34 | 2019-2020 | |
| Pfizer INC. | $28.60 | 2019-2025 | |
| Astellas Pharma US INC | $27.79 | 2019-2020 | |
| Janssen Biotech, INC. | $24.17 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $23.26 | 2025 | Rexulti |
| Ironshore Pharmaceuticals INC. | $15.51 | 2019 | |
| Medtronic, INC. | $15.13 | 2025 | Minimed 780g |
| Merck Sharp & Dohme LLC | $14.93 | 2019 | |
| Sanofi Pasteur INC. | $14.39 | 2020 | |
| Supernus Pharmaceuticals, INC. | $14.24 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.61 | 2025 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $13.58 | 2021 | |
| Genentech USA, INC. | $12.59 | 2019 | |
| Cranial Technologies, INC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.